vs
通用电气医疗（GEHC）与Toll Brothers, Inc.（TOL）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Toll Brothers, Inc.的1.7倍（$5.7B vs $3.4B），Toll Brothers, Inc.净利率更高（13.0% vs 10.3%，领先2.7%），通用电气医疗同比增速更快（7.1% vs 2.7%），过去两年Toll Brothers, Inc.的营收复合增速更高（32.6% vs 10.7%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
Toll Brothers, Inc.是美国知名住宅建造企业，业务涵盖美国境内住宅及商业地产的开发、营销与融资服务。2020年按住宅建造营收统计，该公司为全美第五大房屋建造商，位列《财富》美国500强第411位。
GEHC vs TOL — 直观对比
营收规模更大
GEHC
是对方的1.7倍
$3.4B
营收增速更快
GEHC
高出4.4%
2.7%
净利率更高
TOL
高出2.7%
10.3%
两年增速更快
TOL
近两年复合增速
10.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.7B | $3.4B |
| 净利润 | $588.0M | $446.7M |
| 毛利率 | 39.7% | 24.8% |
| 营业利润率 | 14.5% | 16.5% |
| 净利率 | 10.3% | 13.0% |
| 营收同比 | 7.1% | 2.7% |
| 净利润同比 | -18.4% | -6.0% |
| 每股收益（稀释后） | $1.28 | $4.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEHCTOL
| Q4 25 | $5.7B | $3.4B | ||
| Q3 25 | $5.1B | $2.9B | ||
| Q2 25 | $5.0B | $2.7B | ||
| Q1 25 | $4.8B | $1.9B | ||
| Q4 24 | $5.3B | $3.3B | ||
| Q3 24 | $4.9B | $2.7B | ||
| Q2 24 | $4.8B | $2.8B | ||
| Q1 24 | $4.7B | $1.9B |
净利润GEHCTOL
| Q4 25 | $588.0M | $446.7M | ||
| Q3 25 | $446.0M | $369.6M | ||
| Q2 25 | $486.0M | $352.4M | ||
| Q1 25 | $564.0M | $177.7M | ||
| Q4 24 | $721.0M | $475.4M | ||
| Q3 24 | $470.0M | $374.6M | ||
| Q2 24 | $428.0M | $481.6M | ||
| Q1 24 | $374.0M | $239.6M |
毛利率GEHCTOL
| Q4 25 | 39.7% | 24.8% | ||
| Q3 25 | 38.7% | 25.2% | ||
| Q2 25 | 39.6% | 25.8% | ||
| Q1 25 | 42.1% | 24.7% | ||
| Q4 24 | 42.8% | 26.4% | ||
| Q3 24 | 41.7% | 27.2% | ||
| Q2 24 | 41.4% | 30.4% | ||
| Q1 24 | 40.9% | 27.6% |
营业利润率GEHCTOL
| Q4 25 | 14.5% | 16.5% | ||
| Q3 25 | 12.7% | 16.6% | ||
| Q2 25 | 13.1% | 16.4% | ||
| Q1 25 | 13.2% | 11.8% | ||
| Q4 24 | 15.1% | 18.3% | ||
| Q3 24 | 13.9% | 18.2% | ||
| Q2 24 | 12.6% | 22.0% | ||
| Q1 24 | 11.6% | 15.8% |
净利率GEHCTOL
| Q4 25 | 10.3% | 13.0% | ||
| Q3 25 | 8.7% | 12.6% | ||
| Q2 25 | 9.7% | 12.9% | ||
| Q1 25 | 11.8% | 9.6% | ||
| Q4 24 | 13.6% | 14.3% | ||
| Q3 24 | 9.7% | 13.7% | ||
| Q2 24 | 8.8% | 17.0% | ||
| Q1 24 | 8.0% | 12.3% |
每股收益（稀释后）GEHCTOL
| Q4 25 | $1.28 | $4.51 | ||
| Q3 25 | $0.98 | $3.73 | ||
| Q2 25 | $1.06 | $3.50 | ||
| Q1 25 | $1.23 | $1.75 | ||
| Q4 24 | $1.58 | $4.61 | ||
| Q3 24 | $1.02 | $3.60 | ||
| Q2 24 | $0.93 | $4.55 | ||
| Q1 24 | $0.81 | $2.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $1.3B |
| 总债务越低越好 | $10.0B | — |
| 股东权益账面价值 | $10.4B | $8.3B |
| 总资产 | $36.9B | $14.5B |
| 负债/权益比越低杠杆越低 | 0.96× | — |
8季度趋势，按日历期对齐
现金及短期投资GEHCTOL
| Q4 25 | $4.5B | $1.3B | ||
| Q3 25 | $4.0B | $852.3M | ||
| Q2 25 | $3.7B | $686.5M | ||
| Q1 25 | $2.5B | $574.8M | ||
| Q4 24 | $2.9B | $1.3B | ||
| Q3 24 | $3.5B | $893.4M | ||
| Q2 24 | $2.0B | $1.0B | ||
| Q1 24 | $2.6B | $754.8M |
总债务GEHCTOL
| Q4 25 | $10.0B | — | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | — | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — | ||
| Q1 24 | $9.3B | — |
股东权益GEHCTOL
| Q4 25 | $10.4B | $8.3B | ||
| Q3 25 | $10.0B | $8.1B | ||
| Q2 25 | $9.7B | $7.9B | ||
| Q1 25 | $9.2B | $7.8B | ||
| Q4 24 | $8.4B | $7.7B | ||
| Q3 24 | $8.3B | $7.4B | ||
| Q2 24 | $7.8B | $7.3B | ||
| Q1 24 | $7.4B | $7.0B |
总资产GEHCTOL
| Q4 25 | $36.9B | $14.5B | ||
| Q3 25 | $36.1B | $14.4B | ||
| Q2 25 | $35.5B | $14.2B | ||
| Q1 25 | $33.6B | $13.6B | ||
| Q4 24 | $33.1B | $13.4B | ||
| Q3 24 | $33.9B | $13.4B | ||
| Q2 24 | $31.9B | $13.3B | ||
| Q1 24 | $32.2B | $12.5B |
负债/权益比GEHCTOL
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — | ||
| Q1 24 | 1.25× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $800.0M |
| 自由现金流经营现金流 - 资本支出 | — | $772.2M |
| 自由现金流率自由现金流/营收 | — | 22.6% |
| 资本支出强度资本支出/营收 | 2.4% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.79× |
| 过去12个月自由现金流最近4个季度 | — | $1.0B |
8季度趋势，按日历期对齐
经营现金流GEHCTOL
| Q4 25 | — | $800.0M | ||
| Q3 25 | — | $370.3M | ||
| Q2 25 | $94.0M | $362.8M | ||
| Q1 25 | $250.0M | $-420.8M | ||
| Q4 24 | — | $682.5M | ||
| Q3 24 | — | $175.6M | ||
| Q2 24 | $-119.0M | $459.0M | ||
| Q1 24 | $419.0M | $-307.0M |
自由现金流GEHCTOL
| Q4 25 | — | $772.2M | ||
| Q3 25 | — | $344.9M | ||
| Q2 25 | $8.0M | $347.3M | ||
| Q1 25 | $98.0M | $-438.1M | ||
| Q4 24 | — | $664.3M | ||
| Q3 24 | — | $149.9M | ||
| Q2 24 | $-183.0M | $442.9M | ||
| Q1 24 | $274.0M | $-320.6M |
自由现金流率GEHCTOL
| Q4 25 | — | 22.6% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | 0.2% | 12.7% | ||
| Q1 25 | 2.1% | -23.6% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | -3.8% | 15.6% | ||
| Q1 24 | 5.9% | -16.5% |
资本支出强度GEHCTOL
| Q4 25 | 2.4% | 0.8% | ||
| Q3 25 | 2.1% | 0.9% | ||
| Q2 25 | 1.7% | 0.6% | ||
| Q1 25 | 3.2% | 0.9% | ||
| Q4 24 | 1.9% | 0.5% | ||
| Q3 24 | 1.9% | 0.9% | ||
| Q2 24 | 1.3% | 0.6% | ||
| Q1 24 | 3.1% | 0.7% |
现金转化率GEHCTOL
| Q4 25 | — | 1.79× | ||
| Q3 25 | — | 1.00× | ||
| Q2 25 | 0.19× | 1.03× | ||
| Q1 25 | 0.44× | -2.37× | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | -0.28× | 0.95× | ||
| Q1 24 | 1.12× | -1.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
TOL
| Home Building | $3.4B | 100% |
| Land | $9.4M | 0% |
